At the news
? BEARISHIMPACT 7/10 EFFECT filed Jun 26, 2026 at 00:15 ET
KALA BIO's shelf registration (File No. 333-295667) became effective on June 25, 2026, allowing the company to conduct offerings at any time. The underlying S-3 covers the resale of up to 241,435,910 shares of common stock by selling stockholders, primarily from preferred stock conversions and settlement agreements. This creates a substantial potential dilution overhang for a $47M market cap company.
- Shelf registration effective June 25, 2026, under File No. 333-295667.
- Covers resale of up to 241,435,910 shares of common stock by selling stockholders.
- Shares include 12,000,010 Series AA conversion shares, 226,335,900 Series AAA conversion shares, 2,200,000 LifeSci settlement shares, and 900,000 Baker settlement shares.
- Market cap is approximately $47M, making the potential dilution massive relative to current float.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access